BMLBMLKF 73 Pretax Margin % is 5.18% as of Mar. 2026, which is 40% below its 10-year median of 8.58. GuruFocus rates BMLKF with a GF Score™ of 73/100 and a GF Value™ of $26.44. The stock has 2 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, BML ranks better than 68.32% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BML's Pre-Tax Income for the
three
months ended in Mar. 2026 was $11.7 Mil. BML's Revenue for the
three
months ended in Mar. 2026 was $225.5 Mil. Therefore, BML's pretax margin for the quarter that ended in Mar. 2026 was 5.18%.
The historical rank and industry rank for BML's Pretax Margin % or its related term are showing as below:
BMLKF'
s Pretax Margin % Range Over the Past 10 Years
Min: 6.76 Med: 8.58 Max: 27.05
Current: 7.98
BMLKF's Pretax Margin % is ranked better than 68.32% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.565
vs BMLKF: 7.98
BML (OTCPK:BMLKF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
BML Pretax Margin % Related Terms
BML Pretax Margin % Historical Data
* Premium members only.
The historical data trend for BML's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BMLKF vs TMO, DHR, IDXX: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, BML's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BML Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BML's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where BML's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BML (BMLKF) has a Pretax Margin % of 5.18% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BML and its competitors. This is 40% below median its historical median of 8.58. Over the past decade, BML's Pretax Margin % has ranged from 6.76 to 27.05. According to the industry distribution chart, BML ranks #64 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 31.7%.
Is BML's Pretax Margin % too high?
BML's current Pretax Margin % of 5.18% is 40% below median its 10-year median of 8.58. Over the past 10 years, this metric has ranged from a low of 6.76 to a high of 27.05. Based on the distribution chart, BML ranks #64 out of 202 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, BML has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does BML's Pretax Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, BML ranks #64 out of 202 companies for Pretax Margin %. This puts BML in the upper half of its industry. Historically, BML's own Pretax Margin % has ranged from 6.76 to 27.05 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BML and its competitors. BML's current Pretax Margin % is 5.18%, which is 40% below median its own 10-year median of 8.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
BML (BMLKF) has a current Pretax Margin % of 5.18%. The stock's GF Value™ is $26.44, compared to a current price of $25.21 — trading 4.7% below its estimated fair value. The current Pretax Margin % is 5.18%, which is 40% below median its 10-year median of 8.58. BML's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For BML (BMLKF), the current Pretax Margin % is 5.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BML (BMLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BML stock appears to be undervalued.
The current stock price of $25.21 is trading 4.7% below its estimated GF Value™ of $26.44.
Key valuation signals for BMLKF:
Pretax Margin %: 5.18% (40% below median its 10-year median of 8.58)
GF Value™: $26.44 vs. price of $25.21 (4.7% below fair value)
No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
73GF Score
Get the complete analysis for BMLKF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMLKF has been successfully added to your 
